BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reszke R, Szepietowski JC. End-Stage Renal Disease Chronic Itch and Its Management. Dermatologic Clinics 2018;36:277-92. [DOI: 10.1016/j.det.2018.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Trachtenberg AJ, Collister D, Rigatto C. Recent advances in the treatment of uremic pruritus. Current Opinion in Nephrology & Hypertension 2020;29:465-70. [DOI: 10.1097/mnh.0000000000000625] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Nguyen E, Lim G, Ross SE. Evaluation of Therapies for Peripheral and Neuraxial Opioid-induced Pruritus based on Molecular and Cellular Discoveries. Anesthesiology 2021;135:350-65. [PMID: 34237130 DOI: 10.1097/ALN.0000000000003844] [Reference Citation Analysis]
3 Krajewski PK, Tyczyńska K, Bardowska K, Olczyk P, Nowicka-Suszko D, Janczak D, Augustyniak-Bartosik H, Krajewska M, Szepietowski JC. High Serum IL-31 Concentration Is Associated with Itch among Renal Transplant Recipients. J Clin Med 2022;11:4309. [PMID: 35893400 DOI: 10.3390/jcm11154309] [Reference Citation Analysis]
4 Fishbane S, Mathur V, Germain MJ, Shirazian S, Bhaduri S, Munera C, Spencer RH, Menzaghi F; Trial Investigators. Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients. Kidney Int Rep 2020;5:600-10. [PMID: 32405581 DOI: 10.1016/j.ekir.2020.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Fourzali KM, Yosipovitch G. Management of Itch in the Elderly: A Review. Dermatol Ther (Heidelb) 2019;9:639-53. [PMID: 31549284 DOI: 10.1007/s13555-019-00326-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Tang Y, Cheng S, Wang J, Jin Y, Yang H, Lin Q, Xu S, Hui L, Yin Q, Yang Y, Wu X. Acupuncture for the Treatment of Itch: Peripheral and Central Mechanisms. Front Neurosci 2022;15:786892. [DOI: 10.3389/fnins.2021.786892] [Reference Citation Analysis]
7 Timal RJ, de Gucht V, Rotmans JI, Hensen LCR, Buiten MS, de Bie MK, Putter H, Schalij MJ, Rabelink TJ, Jukema JW. The impact of transvenous cardioverter-defibrillator implantation on quality of life, depression and optimism in dialysis patients: report on the secondary outcome of QOL in the randomized controlled ICD2 trial. Qual Life Res 2021;30:1605-17. [PMID: 33606179 DOI: 10.1007/s11136-020-02744-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wala K, Szepietowski JC. Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review. Pharmaceuticals 2022;15:934. [DOI: 10.3390/ph15080934] [Reference Citation Analysis]
9 Sudarikova AV, Fomin MV, Yankelevich IA, Ilatovskaya DV. The implications of histamine metabolism and signaling in renal function. Physiol Rep 2021;9:e14845. [PMID: 33932106 DOI: 10.14814/phy2.14845] [Reference Citation Analysis]
10 Zhou M, Lin F, Wu X, Ping Z, Xu W, Jin R, Xu A. Inhibition of Fam114A1 protects melanocytes from apoptosis through higher RACK1 expression. Aging (Albany NY) 2021;13:24740-52. [PMID: 34837888 DOI: 10.18632/aging.203712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Krajewski PK, Olczyk P, Krajewska M, Krajewski W, Szepietowski JC. Clinical Characteristics of Itch in Renal Transplant Recipients. Front Med (Lausanne) 2020;7:615334. [PMID: 33553209 DOI: 10.3389/fmed.2020.615334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wieczorek A, Krajewski P, Kozioł-Gałczyńska M, Szepietowski JC. Opioid receptors expression in the skin of haemodialysis patients suffering from uraemic pruritus. J Eur Acad Dermatol Venereol 2020;34:2368-72. [PMID: 32170896 DOI: 10.1111/jdv.16360] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
13 Agarwal P, Garg V, Karagaiah P, Szepietowski JC, Grabbe S, Goldust M. Chronic Kidney Disease-Associated Pruritus. Toxins (Basel) 2021;13:527. [PMID: 34437400 DOI: 10.3390/toxins13080527] [Reference Citation Analysis]
14 Wang Z, Jiang C, Yao H, Chen O, Rahman S, Gu Y, Zhao J, Huh Y, Ji R. Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition. Brain 2021;144:665-81. [DOI: 10.1093/brain/awaa430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
15 Schricker S, Kimmel M. Unravelling the pathophysiology of chronic kidney disease-associated pruritus. Clin Kidney J 2021;14:i23-31. [PMID: 34987780 DOI: 10.1093/ckj/sfab200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nair D, Finkelstein FO. Pruritus as a Patient-Reported Primary Trial End Point in Hemodialysis: Evaluation and Implications. Am J Kidney Dis 2020;76:148-51. [PMID: 32334827 DOI: 10.1053/j.ajkd.2020.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sorour NE, Elesawy FM, Tabl HA, Ibrahim ME, Akl EM. Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients. Clin Cosmet Investig Dermatol 2019;12:109-14. [PMID: 30799944 DOI: 10.2147/CCID.S190917] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
18 Świerczyńska K, Krajewski PK, Nowicka-suszko D, Białynicki-birula R, Krajewska M, Szepietowski JC. The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect? Toxins 2022;14:197. [DOI: 10.3390/toxins14030197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Makar M, Smyth B, Brennan F. Chronic Kidney Disease-Associated Pruritus: A Review. Kidney Blood Press Res 2021;46:659-69. [PMID: 34515143 DOI: 10.1159/000518391] [Reference Citation Analysis]
20 Guo J, Ba X, Matsuda M, Wei P, Jiang C, Sun W, Xiao L, Xiong D, Liao X, Hao Y. Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System. Front Neurosci 2020;14:581977. [PMID: 33071749 DOI: 10.3389/fnins.2020.581977] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Yao C, Zhou L, Huang Q. The occurrence and potential predictive factors of major adverse cardiac and cerebral events in end-stage renal disease patients on continuous ambulatory peritoneal dialysis: A prospective cohort study. Medicine (Baltimore) 2021;100:e24616. [PMID: 33725825 DOI: 10.1097/MD.0000000000024616] [Reference Citation Analysis]
22 Liu JW, Tan Y, Chen T, Liu W, Qian YT, Ma DL. Location, Spreading and Oral Corticosteroids are Associated with Insomnia in Vitiligo Patients: A Case-Control Study. Clin Cosmet Investig Dermatol 2021;14:971-80. [PMID: 34377005 DOI: 10.2147/CCID.S322963] [Reference Citation Analysis]
23 Liu Y, Hsiao H, Wang JC, Liu Y, Wu S. Effectiveness of nalbuphine, a κ‐opioid receptor agonist and μ‐opioid receptor antagonist, in the inhibition of INa , IK(M) , and IK(erg) unlinked to interaction with opioid receptors. Drug Dev Res 2019;80:846-56. [DOI: 10.1002/ddr.21568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Vuksanović S, Adamov N, Balo M, Trbojević-stanković J. Prevalence and characteristics of pruritus in patients treated with different dialysis modalities. Medicinski podmladak 2020;71:1-7. [DOI: 10.5937/mp71-29019] [Reference Citation Analysis]